Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
ers of a special ethics panel, including both Democrats and Republicans, who are paying attention. Good for them. The conduct of Rep. Chris Collins, R-Clarence, exposed a range of issues Congress needs to treat as tumors, and cut them out. Collins was indicted last year on allegations of insider trading. B
2 mentions1 same-page
Page ?Same page
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
ers of a special ethics panel, including both Democrats and Republicans, who are paying attention. Good for them. The conduct of Rep. Chris Collins, R-Clarence, exposed a range of issues Congress needs to treat as tumors, and cut them out. Collins was indicted last year on allegations of insider trading. B
2 mentions1 same-page
Page ?Same page
regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have benefited other companies — and may even have been
ers of a special ethics panel, including both Democrats and Republicans, who are paying attention. Good for them. The conduct of Rep. Chris Collins, R-Clarence, exposed a range of issues Congress needs to treat as tumors, and cut them out. Collins was indicted last year on allegations of insider trading. B
Sponsored
Mutual Connections (220)
Entities connected to both Investigational New Drug (IND and R-Clarence
Donald Trump
PERSON4 w/ Investigational·3 w/ R-Clarence
CW
Courtney Wild
PERSON4 w/ Investigational·3 w/ R-Clarence
Department of Justice
ORGANIZATION4 w/ Investigational·3 w/ R-Clarence
Virginia Giuffre
PERSON4 w/ Investigational·3 w/ R-Clarence
the Securities and Exchange Commission
ORGANIZATION4 w/ Investigational·3 w/ R-Clarence
Stephen Hawking
PERSON3 w/ Investigational·3 w/ R-Clarence
Marc Rich
PERSON3 w/ Investigational·3 w/ R-Clarence
U.S. Virgin Islands
LOCATION3 w/ Investigational·3 w/ R-Clarence
Bill Clinton
PERSON3 w/ Investigational·3 w/ R-Clarence
Alexander Acosta
PERSON3 w/ Investigational·3 w/ R-Clarence
Bradley Edwards
PERSON3 w/ Investigational·3 w/ R-Clarence
Ric Bradshaw
PERSON3 w/ Investigational·3 w/ R-Clarence
Julie K. Brown
PERSON3 w/ Investigational·3 w/ R-Clarence
South Florida
LOCATION3 w/ Investigational·3 w/ R-Clarence
Gloria Allred
PERSON3 w/ Investigational·3 w/ R-Clarence
Teterboro
LOCATION3 w/ Investigational·3 w/ R-Clarence
Kenneth Marra
PERSON3 w/ Investigational·3 w/ R-Clarence
JS
Jack Scarola
PERSON3 w/ Investigational·3 w/ R-Clarence
Eric Trump
PERSON3 w/ Investigational·3 w/ R-Clarence
Michael Flynn
PERSON3 w/ Investigational·3 w/ R-Clarence